双能量CT能否替代灌注CT用于晚期肝细胞癌的功能评估
单中心IRB批准研究纳入16例接受索拉非尼或放射栓塞治疗的晚期肝细胞癌患者,同期行动态灌注CT与单源快速kV切换双能量CT多期扫描。晚期动脉期碘浓度与血流量相关参数及血容量相关参数均显著相关,门静脉期碘浓度主要反映血容量;双能量CT辐射剂量显著低于灌注CT。
要点
- 晚期动脉期碘浓度与动脉血流量及血容量均强相关,可反映肿瘤灌注变化。
- 门静脉期碘浓度主要反映肿瘤血容量。
- 双能量CT较灌注CT显著降低辐射剂量。
核心结论
- 在晚期肝细胞癌病灶中,双能量CT derived晚期动脉期碘浓度与动脉血流量和血容量均强相关,门静脉期碘浓度主要反映血容量,使双能量CT能够同时评估形态学与灌注变化。
研究设计与样本
- 单中心IRB批准研究,纳入16例接受索拉非尼或放射栓塞治疗的晚期肝细胞癌患者,同期行动态灌注CT与多期双能量CT(单源快速kV切换双能量CT扫描仪),计算肝细胞癌晚期动脉期和门静脉期碘浓度及血流量相关和血容量相关灌注参数图,采用混合效应模型分析碘浓度与灌注参数的关系,Bonferroni校正后p<0.05为显著。
诊断标准与关键数值
- 肝细胞癌平均晚期动脉期碘浓度为22.7±12.7 mg/mL,平均门静脉期碘浓度为18.7±8.3 mg/mL;晚期动脉期碘浓度与血容量(F=28.52,p<0.0001)、动脉血流量(F=17.62,p<0.0001)、肝灌注指数(F=28.24,p<0.0001)、正性强化积分(F=66.75,p<0.0001)及平均上升斜率(F=32.96,p<0.0001)显著相关;门静脉期碘浓度主要与血容量(F=29.68,p<0.0001)和正性强化积分(F=66.75,p<0.0001)相关。
临床应用与阅片要点
- 晚期动脉期碘浓度可同时反映动脉血流量和血容量,门静脉期碘浓度主要反映血容量,双能量CT可提供形态学与灌注信息且辐射剂量显著低于灌注CT。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine the degree of relationship between iodine concentrations derived from dual-energy CT (DECT) and perfusion CT parameters in patients with advanced HCC under treatment.
METHODS: In this single-centre IRB approved study, 16 patients with advanced HCC treated with sorafenib or radioembolization who underwent concurrent dynamic perfusion CT and multiphase DECT using a single source, fast kV switching DECT scanner were included. Written informed consent was obtained for all patients. HCC late-arterial and portal iodine concentrations, blood flow (BF)-related and blood volume (BV)-related perfusion parameters maps were calculated. Mixed-effects models of the relationship between iodine concentrations and perfusion parameters were computed. An adjusted p value (Bonferroni method) < 0.05 was considered significant.
RESULTS: Mean HCC late-arterial and portal iodine concentrations were 22.7±12.7 mg/mL and 18.7±8.3 mg/mL, respectively. Late-arterial iodine concentration was significantly related to BV (mixed-effects model F statistic (F)=28.52, p<0.0001), arterial BF (aBF, F=17.62, p<0.0001), hepatic perfusion index (F=28.24, p<0.0001), positive enhancement integral (PEI, F=66.75, p<0.0001) and mean slope of increase (F=32.96, p<0.0001), while portal-venous iodine concentration was mainly related to BV (F=29.68, p<0.0001) and PEI (F=66.75, p<0.0001).
CONCLUSIONS: In advanced HCC lesions, DECT-derived late-arterial iodine concentration is strongly related to both aBF and BV, while portal iodine concentration mainly reflects BV, offering DECT the ability to evaluate both morphological and perfusion changes.
KEY POINTS: • Late-arterial iodine concentration is highly related to arterial BF and BV. • Portal iodine concentration mainly reflects tumour blood volume. • Dual-energy CT offers significantly decreased radiation dose compared with perfusion CT.
引用
- Mulé S, Pigneur F, Quelever R, et al. Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma? Eur Radiol. 2017. PMID: 29168007. doi:10.1007/s00330-017-5151-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。